---
reference_id: "DOI:10.1186/s13023-024-03411-7"
title: "Exploring molecular spectrum in thai patients with maple syrup urine disease: unveiling a common variant"
authors:
- Panisara Lakkhana
- Thipwimol Tim-Aroon
- Arthaporn Khongkraparn
- Saisuda Noojarern
- Parith Wongkittichote
- Khunton Wichajarn
- Chulaluck Kuptanon
- Boonchai Boonyawat
- Kanya Suphapeetiporn
- Karn Wejaphikul
- GoHun Seo
- Duangrurdee Wattanasirichaigoon
journal: Orphanet Journal of Rare Diseases
year: '2024'
doi: 10.1186/s13023-024-03411-7
content_type: abstract_only
---

# Exploring molecular spectrum in thai patients with maple syrup urine disease: unveiling a common variant
**Authors:** Panisara Lakkhana, Thipwimol Tim-Aroon, Arthaporn Khongkraparn, Saisuda Noojarern, Parith Wongkittichote, Khunton Wichajarn, Chulaluck Kuptanon, Boonchai Boonyawat, Kanya Suphapeetiporn, Karn Wejaphikul, GoHun Seo, Duangrurdee Wattanasirichaigoon
**Journal:** Orphanet Journal of Rare Diseases (2024)
**DOI:** [10.1186/s13023-024-03411-7](https://doi.org/10.1186/s13023-024-03411-7)

## Content

Abstract
Background
Maple syrup urine disease (MSUD) is a rare autosomal recessive metabolic disorder caused by variants in any of the following genes: BCKDHA, BCKDHB, and DBT gene. Previous reports have highlighted a variety of common causing genes and variants among different ethnic groups affected by MSUD. This study is the first to describe the molecular characteristics, potential common variants, clinical phenotypes, and treatment outcomes of 20 Thai MSUD patients before the implementation of expanded newborn screening in Thailand.

Results
A cross-sectional, multicenter study was conducted, including twenty Thai MSUD patients from 1997 to 2023. Most of the patients presented with classic neonatal onset (95%). The mortality rate was 20%, while global developmental delay was observed in 40% of the patients. Variants in the BCKDHB gene were detected in 85% (17/20) of the patients, while the BCKDHA gene accounted for 15% (3/20). The study identified the 11-kb deletion involving 5â€™UTR, exon 1, and intron 1 in the BCKDHB gene, from a position of g.80102385 to g.80113453 (NC_000006.12), accounting for 50% of all variants (20/40 alleles) in Thai MSUD patients. All patients with the 11-kb deletion in BCKDHB presented with the classic type. The gap-PCR for this common deletion was established in the study.

Conclusion
This study is the first to describe the clinical and molecular spectrum of Thai MSUD patients before the implementation of expanded NBS. The 11-kb deletion involving exon 1 in the BCKDHB emerges as the most common variant among Thai individuals with MSUD. Furthermore, the gap-PCR test for detecting the 11-kb exon 1 deletion status holds the potential for integration into stepwise molecular analysis following positive expanded newborn screening.